Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Short-term Investments: 2009-2025

Historic Short-term Investments for Gyre Therapeutics (GYRE) over the last 15 years, with Sep 2025 value amounting to $19.6 million.

  • Gyre Therapeutics' Short-term Investments rose 112.95% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year increase of 112.95%. This contributed to the annual value of $14.9 million for FY2024, which is N/A change from last year.
  • Per Gyre Therapeutics' latest filing, its Short-term Investments stood at $19.6 million for Q3 2025, which was up 9.76% from $17.9 million recorded in Q2 2025.
  • Gyre Therapeutics' Short-term Investments' 5-year high stood at $24.0 million during Q1 2021, with a 5-year trough of $2.5 million in Q4 2021.
  • Moreover, its 2-year median value for Short-term Investments was $14.8 million (2025), whereas its average is $13.3 million.
  • In the last 5 years, Gyre Therapeutics' Short-term Investments tumbled by 94.89% in 2021 and then spiked by 112.95% in 2025.
  • Quarterly analysis of 3 years shows Gyre Therapeutics' Short-term Investments stood at $2.5 million in 2021, then reached $14.9 million in 2024, then spiked by 112.95% to $19.6 million in 2025.
  • Its Short-term Investments was $19.6 million in Q3 2025, compared to $17.9 million in Q2 2025 and $14.8 million in Q1 2025.